Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maureen P Martin

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2008
Novel KIR3DL1 alleles and their expression levels on NK cells: convergent evolution of KIR3DL1 phenotype variation?Rasmi Thomas, Eriko Yamada, Galit Alter, et al.
The Journal of Experimental Medicine|April 6, 2005
Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen lociMary Carrington, Sophia Wang, Maureen P Martin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 21, 2007
Detection of KIR3DS1 on the cell surface of peripheral blood NK cells facilitates identification of a novel null allele and assessment of KIR3DS1 expression during HIV-1 infectionVéronique Pascal, Eriko Yamada, Maureen P Martin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 22, 2006
Cutting Edge: Allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-BHathairat Thananchai, Geraldine Gillespie, Maureen P Martin, et al.
Immunogenetics|January 27, 2023
Comparison between qPCR and RNA-seq reveals challenges of quantifying HLA expressionVitor R C Aguiar, Erick C Castelli, Richard M Single, et al.
The Journal of Experimental Medicine|December 17, 2009
HLA-B*35-Px-mediated acceleration of HIV-1 infection by increased inhibitory immunoregulatory impulsesJinghe Huang, James J Goedert, Eric J Sundberg, et al.
Journal of Virology|November 27, 2004
Association of DC-SIGN promoter polymorphism with increased risk for parenteral, but not mucosal, acquisition of human immunodeficiency virus type 1 infectionMaureen P Martin, Michael M Lederman, Holli B Hutcheson, et al.
Nature Genetics|July 23, 2002
Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDSMaureen P Martin, Xiaojiang Gao, Jeong-Hee Lee, et al.
The Journal of Infectious Diseases|August 16, 2013
Associations between human leukocyte antigen class I variants and the Mycobacterium tuberculosis subtypes causing diseaseMuneeb Salie, Lize van der Merwe, Marlo Möller, et al.
The Journal of Experimental Medicine|November 21, 2007
Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypesGalit Alter, Maureen P Martin, Nickolas Teigen, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2008
Novel KIR3DL1 alleles and their expression levels on NK cells: convergent evolution of KIR3DL1 phenotype variation?Rasmi Thomas, Eriko Yamada, Galit Alter, et al.
The Journal of Experimental Medicine|April 6, 2005
Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen lociMary Carrington, Sophia Wang, Maureen P Martin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 21, 2007
Detection of KIR3DS1 on the cell surface of peripheral blood NK cells facilitates identification of a novel null allele and assessment of KIR3DS1 expression during HIV-1 infectionVéronique Pascal, Eriko Yamada, Maureen P Martin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 22, 2006
Cutting Edge: Allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-BHathairat Thananchai, Geraldine Gillespie, Maureen P Martin, et al.
Immunogenetics|January 27, 2023
Comparison between qPCR and RNA-seq reveals challenges of quantifying HLA expressionVitor R C Aguiar, Erick C Castelli, Richard M Single, et al.
The Journal of Experimental Medicine|December 17, 2009
HLA-B*35-Px-mediated acceleration of HIV-1 infection by increased inhibitory immunoregulatory impulsesJinghe Huang, James J Goedert, Eric J Sundberg, et al.
Journal of Virology|November 27, 2004
Association of DC-SIGN promoter polymorphism with increased risk for parenteral, but not mucosal, acquisition of human immunodeficiency virus type 1 infectionMaureen P Martin, Michael M Lederman, Holli B Hutcheson, et al.
Nature Genetics|July 23, 2002
Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDSMaureen P Martin, Xiaojiang Gao, Jeong-Hee Lee, et al.
The Journal of Infectious Diseases|August 16, 2013
Associations between human leukocyte antigen class I variants and the Mycobacterium tuberculosis subtypes causing diseaseMuneeb Salie, Lize van der Merwe, Marlo Möller, et al.
The Journal of Experimental Medicine|November 21, 2007
Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypesGalit Alter, Maureen P Martin, Nickolas Teigen, et al.
Pageof 7